Veracyte Inc. logo

Veracyte Inc.

VCYT | NASDAQ
Chart Builder DCF Calculator
$43.53
+$2.01 (+4.84%)
Sep 22, 2026, 2:45 PM ET · Market open

Company Profile

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

Key Executives

Name Position
Marc A. Stapley Chief Executive Officer & Director
Rebecca Chambers Executive Vice President & Chief Financial Officer
Steven French Senior Vice President & Chief Information Officer
Annie McGuire Executive VP, General Counsel & Head of Market Access
John Leite Global Chief Commercial Officer
Jonathan Wygant Vice President & Chief Accounting Officer
Karen Possemato Senior Vice President of Corporate Marketing, Communications & Commercial Operations
Keith Gligorich Senior Vice President of Global Operations
Kelly Gura Director of Investor Relations
Kevin Richard Haas Chief Development and Technology Officer
Phillip G. Febbo Chief Scientific & Medical Officer
Tracy Ward Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Sep 04, 2026 4 Filing
Sep 04, 2026 4 Filing
Sep 04, 2026 4 Filing
Sep 04, 2026 4 Filing
Sep 04, 2026 4 Filing
Sep 04, 2026 4 Filing
Sep 03, 2026 4 Filing
Jul 31, 2026 10-Q Quarterly Report
Jul 30, 2026 8-K Current Report
Jun 22, 2026 4 Filing
View All SEC Filings
Veracyte Inc.
Veracyte Inc. logo
Country United States
IPO Date Oct 28, 2013
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 755
CEO Marc Stapley

Contact Details

6000 Shoreline Court South San Francisco, California 94080 United States

Stock Details

Ticker Symbol VCYT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001384101
CUSIP Number 92337F107
ISIN Number US92337F1075
SIC Code 8071

© 2026 bestshares.com. All rights reserved.